Clinical trials demonstrate significant weight reduction, with patients losing approximately 15% of body weight over 68 weeks with semaglutide (STEP 1 trial) and up to 21% with tirzepatide 15 mg over 72 weeks (SURMOUNT-1 trial)
Obesity is one of the most serious health issues facing the nation and is associated with many health conditions, ranging from cardiovascular diseases to cancers, so effective medications to help people control their weight could have substantial health benefits
You'll see links throughout to related topics that explain why things happen , what options exist , and what tends to help in real life
Out of over 17,000 patients on Tirzepatide, 10 reported gastroparesis
Key Takeaways North America led the GLP-1 market by holding a major share of 57% in 2025
Zorn S, Bounds R, Williamson A, et al